Literature DB >> 8674084

The effectiveness of O2 administration for transient ischemic attacks in moyamoya disease in children.

J Fujiwara1, S Nakahara, T Enomoto, Y Nakata, H Takita.   

Abstract

Moyamoya disease is a cerebrovascular obstructive disease of unknown etiology. The rebuild-up phenomenon, slowing of waves on electroencephalogram (EEG) seen after cessation of hyperventilation (HV), is one of the characteristic phenomena of the disease and is thought to be related to a development of its symptoms. Therefore, we investigated the mechanism involved in the rebuild-up phenomenon to clarify the mechanism of development of transient ischemic attack (TIA) in moyamoya disease. Ten patients with moyamoya disease were studied; they ranged in age from 7 to 17 years. The power spectra of the EEGs in the occipital region were obtained with a Berg Fourier EEG analyzer for quantitative analysis. Arterial blood gas change (pH, PaO2, PaCO2), respiratory pattern (abdominal and nasal), tidal volume and respiratory rate were analyzed simultaneously every 30 s-1 min before, during, and after HV. The slow wave power spectrum (rebuild-up) increased and symptoms of TIA developed as a result of the sharp decrease in PaO2 (PaO2 60.5 +/- 15.4 mmHg) after cessation of HV. Based on the fact that hypoxemia was playing a main role, 100% oxygen was administered at a rate of 0.5 l/min in 4 cases where the rebuild-up phenomenon was clear. The EEG power spectra and arterial blood gas were analyzed during rebuild-up with and without O2 administration. The effectiveness of O2 administration at the beginning of rebuild-up as measure to prevent the symptoms was checked by a recovery rate of slow wave power percentage, a recovery time of slow wave power percent and by clinical observation. The recovery rates were 11.8 +/- 4.2%/min and 5.5 +/- 4.0%/min with and without O2 inhalation, respectively (P < 0.001). Recovery times of slow wave power percentage were 4.3 +/- 1.8 min and 8.1 +/- 1.2 min with and without O2 inhalation, respectively (P < 0.01). Thus, oxygen administration soon after the cessation of HV was shown to be effective in eliminating the rebuild-up phenomenon and hence in abolishing its symptoms.

Entities:  

Mesh:

Year:  1996        PMID: 8674084     DOI: 10.1007/bf00819498

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  11 in total

1.  Metabolic and electroencephalographic effects of hyperventilation. Experimental studies of brain oxygen and carbon dioxide tension, pH, EEG and blood flow during hyperventilation.

Authors:  J S MEYER; F GOTOH
Journal:  Arch Neurol       Date:  1960-11

2.  [Usefulness of single-photon emission-computed tomography with hyperventilation for the diagnosis of moyamoya disease].

Authors:  S Hamano; K Fukushima; T Nara; T Aihara; K Maekawa
Journal:  No To Hattatsu       Date:  1990-07

3.  Effects of encephalo-duro-arterio-synangiosis on childhood moyamoya patients--swift disappearance of ischemic attacks and maintenance of mental capacity.

Authors:  Y Matsushima; M Aoyagi; Y Koumo; Y Takasato; T Yamaguchi; H Masaoka; R Suzuki; K Ohno
Journal:  Neurol Med Chir (Tokyo)       Date:  1991-11       Impact factor: 1.742

4.  Characteristic EEG findings in childhood moyamoya syndrome.

Authors:  G Kurlemann; G Fahrendorf; W Krings; J Sciuk; D Palm
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

5.  [Changes in symptoms after encephalo-duro-arterio-synangiosis (EDAS) in pediatric moyamoya disease].

Authors:  Y Matsushima; T Yamaguchi; Y Takasato; S Tomida; T Fukumoto; R Suzuki; H Tomita; Y Inaba
Journal:  No To Hattatsu       Date:  1986-01

6.  [Five year observation of two children of moyamoya disease after encephalo-duro-arterio-synangiosis (EDAS) operation].

Authors:  S Tomida; Y Matsushima; U Ito; S Yamazaki; Y Inaba
Journal:  No To Hattatsu       Date:  1986-01

7.  Surgical treatment of moyamoya disease: operative technique for encephalo-duro-arterio-myo-synangiosis, its follow-up, clinical results, and angiograms.

Authors:  K Kinugasa; S Mandai; I Kamata; K Sugiu; T Ohmoto
Journal:  Neurosurgery       Date:  1993-04       Impact factor: 4.654

8.  Mental outcome following encephaloduroarteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age.

Authors:  Y Matsushima; M Aoyagi; H Masaoka; R Suzuki; K Ohno
Journal:  Childs Nerv Syst       Date:  1990-12       Impact factor: 1.475

9.  Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease.

Authors:  J Karasawa; H Touho; H Ohnishi; S Miyamoto; H Kikuchi
Journal:  J Neurosurg       Date:  1992-07       Impact factor: 5.115

10.  [Regional cerebral blood flow in moyamoya disease using 123-I IMP-SPECT--follow up study before and after therapy].

Authors:  T Konishi; Y Naganuma; K Hongo; M Murakami; M Yamatani; T Okada; A Takaku
Journal:  No To Hattatsu       Date:  1991-09
View more
  2 in total

1.  Surgical management of moyamoya syndrome.

Authors:  Edward R Smith; R Michael Scott
Journal:  Skull Base       Date:  2005-02

2.  Moyamoya disease and surgical intervention.

Authors:  Jay W Rhee; Suresh N Magge
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.